Vimarsana
Biggest News Aggregation in the World

Month Safety News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Month Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Month Safety Today - Breaking & Trending Today

Witches are not responsible for road traffic crashes in Nigeria - FRSC - Vimarsana News

Witches are not responsible for road traffic crashes in Nigeria - FRSC

The Federal Road Safety Commission, (FRSC) on Thursday, said that witches were not responsible for road traffic crashes in Nigeria but recklessness of road users. | Pulse Nigeria

Source: pulse.ng
Witches not responsible for road accidents – FRSC tells Nigerians - Vimarsana News

Witches not responsible for road accidents – FRSC tells Nigerians

The Federal Road Safety Commission (FRSC) on Thursday, said that witches were not responsible for road traffic crashes in Nigeria but recklessness of road

EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update - Vimarsana News

EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 and Durasert® Technology Developments and Provide a Financial Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901 - Vimarsana News

EyePoint Pharmaceuticals Investor Day to Highlight EYP-1901

- Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD announced at ASRS 2022...

Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) - Vimarsana News

Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine)

16 presentations will examine safety and efficacy of AJOVY and AUSTEDOTEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data for two of the company’s neurology portfolio treatments, AJOVY® (fr...